DePuy CEO Testifies On Aussie Pullout In Hip Implant Suit

Law360, Los Angeles (January 30, 2013, 5:28 PM EST) -- DePuy Inc. continued selling its ASR XL hip implant in the U.S. for nearly a year after pulling the product from Australia because of doctors' complaints, the Johnson & Johnson Co. subsidiary’s president told jurors during videotaped testimony in a bellwether product liability trial Wednesday.

Andrew Ekdahl, who has been DePuy's president since 2011 and who worked in the company's marketing department before that, testified in California state court that minutes from a September 2009 meeting of the company's marketing department showed a recommendation that DePuy...
To view the full article, register now.